A specialist laboratory service based at Vision Park has acquired another Cambridge-based company for an undisclosed sum.
Source Bioscience is considered an industry leader in the areas of genomic services and histopathology diagnostics. It works with the biotechnology, pharmaceutical, healthcare and academic sectors.
And last month, the company announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL) which specialises in clinical healthcare testing. It was said the move will bolster Source Bioscience’s clinical diagnostics portfolio from its state-of-the-art clinical labs in Histon.
‘Extremely pleased’
Jay LeCoque, Chairman and CEO of Source BioScience, said: “We’re extremely pleased to welcome Cambridge Clinical Laboratories into our team here at Source Bioscience. CCL has a longstanding reputation for its expertise in personalised clinical diagnostic services, and as such, represented the ideal opportunity to complete our service offerings.”
CCL staff and equipment will relocate to Source Bioscience’s labs at Vision Park.
Tony Cooke, former CEO and Chief Scientific Officer at CCL, added: “We welcome the opportunity to join forces with Source, which will allow us to bring together the talent and expertise of both companies.”
Leave a Reply